Cayman was founded in 1980 and has maintained its mission of providing high-quality and cost-effective research products to researchers worldwide over the past 20 years of development. The company currently provides over 2138 biochemical and immunological reagents, covering research fields such as tumors, nitric oxide, neurology, apoptosis, oxidative damage, endocrinology, etc. A very distinctive detection kit includes arachidonic acid like substances, free biomarkers, cyclic nucleosides, hormones, and nitrogen oxides. In addition, a variety of high-quality reagents are provided, such as arachidonic acid like substances, nitrogen oxide reagents, and many related lipids, fatty acids, enzymes, and antibodies. Cayman is very willing to accept the requirements of customers from all over the world to synthesize complex and unstable molecules.
